• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝外胆管癌胆道微生物群失调的特征。

Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.

机构信息

Early Detection of Colon Cancer Using Molecular and Microbial Markers (EC2M3)-EA 7375 Team, University Paris-Est Creteil (UPEC), Créteil, France.

Bioinformatic Core Facility, IMRB UMR 955 - INSERM, UPEC, Créteil Cedex, France.

出版信息

PLoS One. 2021 Mar 9;16(3):e0247798. doi: 10.1371/journal.pone.0247798. eCollection 2021.

DOI:10.1371/journal.pone.0247798
PMID:33690612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7943025/
Abstract

Extrahepatic cholangiocarcinoma (CCA) accounts for 3% of digestive cancers. The role of biliary microbiota as an environment-related modulator has been scarcely investigated in CCA, and the putative impact of associated diseases has not been yet assessed. We characterized the biliary microbiota in CCA patients in order to identify a specific CCA-related dysbiosis. The biliary effluents were collected through an endoscopic retrograde pancreatic cholangiography (ERCP) examination involving 28 CCA and 47 patients with gallstones, herein considered as controls. The biliary effluents were submitted to bacterial DNA extraction and 16S rRNA sequencing, using Illumina technology. Overall, 32% of CCA and 22% of controls displayed another associated disease, such as diabetes, pancreatitis, inflammatory bowel disease, or primary sclerosing cholangitis. Such associated diseases were considered in the comparisons that were made. Principal coordinate analysis (PCoA) detected a significant disparity of biliary microbiota composition between CCA patients and controls without an associated disease. Amongst the most abundant phyla, Proteobacteria did not significantly differ between CCA patients and controls, whereas Firmicutes levels were lower and Bacteroidetes higher in CCAs' biliary microbiota than in the controls' microbiota. The most abundant genera were Enterococcus, Streptococcus, Bacteroides, Klebsiella, and Pyramidobacter in CCA's biliary microbiota. Additionally, levels of Bacteroides, Geobacillus, Meiothermus, and Anoxybacillus genera were significantly higher in CCA patients' biliary microbiota, without an associated disease, in comparison with controls. A specific CCA-related dysbiosis was identified as compared to controls independently from associated diseases. This suggests that a microorganism community may be involved in CCA pathogenesis.

摘要

肝外胆管癌(CCA)占消化系统癌症的 3%。胆道微生物群作为一种与环境相关的调节剂,其在 CCA 中的作用尚未得到充分研究,相关疾病的潜在影响也尚未评估。我们对 CCA 患者的胆道微生物群进行了特征描述,以确定一种特定的与 CCA 相关的菌群失调。通过内镜逆行胰胆管造影(ERCP)检查收集胆道流出物,该检查涉及 28 例 CCA 患者和 47 例胆石症患者,后者被认为是对照组。对胆道流出物进行细菌 DNA 提取和 16S rRNA 测序,使用 Illumina 技术。总体而言,32%的 CCA 患者和 22%的对照组患有另一种相关疾病,如糖尿病、胰腺炎、炎症性肠病或原发性硬化性胆管炎。在进行比较时考虑了这些相关疾病。主坐标分析(PCoA)检测到 CCA 患者和无相关疾病的对照组之间胆道微生物群组成存在显著差异。在最丰富的门中,变形菌门在 CCA 患者和对照组之间没有显著差异,而厚壁菌门水平在 CCA 患者的胆道微生物群中较低,拟杆菌门水平较高。CCA 胆道微生物群中最丰富的属为肠球菌属、链球菌属、拟杆菌属、克雷伯菌属和Pyramidobacter 属。此外,在无相关疾病的情况下,CCA 患者胆道微生物群中Bacteroides、Geobacillus、Meiothermus 和 Anoxybacillus 属的水平显著高于对照组。与对照组相比,CCA 患者胆道微生物群中存在一种特定的与 CCA 相关的菌群失调,独立于相关疾病。这表明微生物群落可能参与了 CCA 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/25d364d68f76/pone.0247798.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/5c33e54ae1fa/pone.0247798.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/270de54b22f0/pone.0247798.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/25d364d68f76/pone.0247798.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/5c33e54ae1fa/pone.0247798.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/270de54b22f0/pone.0247798.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/7943025/25d364d68f76/pone.0247798.g003.jpg

相似文献

1
Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.肝外胆管癌胆道微生物群失调的特征。
PLoS One. 2021 Mar 9;16(3):e0247798. doi: 10.1371/journal.pone.0247798. eCollection 2021.
2
A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma.胆管结石或远端胆管癌患者胆道微生物群的初步研究。
Biomed Res Int. 2019 Sep 25;2019:1092563. doi: 10.1155/2019/1092563. eCollection 2019.
3
New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis.胆管癌择期手术候选者面临的新挑战:利用微生物失调。
Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8.
4
Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.原发性硬化性胆管炎中的胆汁微生物群:对疾病进展和胆管发育异常的影响。
PLoS One. 2017 Aug 10;12(8):e0182924. doi: 10.1371/journal.pone.0182924. eCollection 2017.
5
Bile Microbiota in Patients with Pigment Common Bile Duct Stones.胆汁微生物群在色素性胆总管结石患者中的变化。
J Korean Med Sci. 2021 Apr 19;36(15):e94. doi: 10.3346/jkms.2021.36.e94.
6
Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma.慢性华支睾吸虫感染与微生态改变在胆管癌发生中的关联。
Clin Transl Gastroenterol. 2020 Dec 22;12(1):e00292. doi: 10.14309/ctg.0000000000000292.
7
Infection with Helicobacter bilis but not Helicobacter hepaticus was Associated with Extrahepatic Cholangiocarcinoma.感染胆汁螺杆菌而非肝螺杆菌与肝外胆管癌有关。
Helicobacter. 2015 Jun;20(3):223-30. doi: 10.1111/hel.12195. Epub 2015 Jan 13.
8
Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study.大规模研究中与胆固醇性胆囊结石相关的肠道微生物失调和细菌群落组装。
BMC Genomics. 2013 Oct 1;14:669. doi: 10.1186/1471-2164-14-669.
9
Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients.胆汁微生物组分析鉴定胆总管结石和胆管癌患者之间的区域微生物群。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):233-240. doi: 10.31557/APJCP.2021.22.1.233.
10
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma.促炎胆道微生物群在原发性硬化性胆管炎和胆管癌中的潜在作用
Cancers (Basel). 2022 Apr 24;14(9):2120. doi: 10.3390/cancers14092120.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.应对炎症性肠病和原发性硬化性胆管炎中的肿瘤风险
Cancers (Basel). 2025 Jun 27;17(13):2165. doi: 10.3390/cancers17132165.
3
Intestinal microbiota in adults with cholangiocarcinoma identifies the dysregulated Blautia species and bile acid metabolic pathways.

本文引用的文献

1
SHAMAN: a user-friendly website for metataxonomic analysis from raw reads to statistical analysis.SHAMAN:一个用户友好的网站,用于从原始读取到统计分析的元分类分析。
BMC Bioinformatics. 2020 Aug 10;21(1):345. doi: 10.1186/s12859-020-03666-4.
2
Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.靶向肠道微生物组作为原发性硬化性胆管炎的治疗方法:概念框架。
Am J Gastroenterol. 2020 Jun;115(6):814-822. doi: 10.14309/ajg.0000000000000604.
3
Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India.
胆管癌成年患者的肠道微生物群可识别失调的布劳特氏菌属物种和胆汁酸代谢途径。
BMC Gastroenterol. 2025 Jul 7;25(1):506. doi: 10.1186/s12876-025-04096-3.
4
Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.以单细胞分辨率解析肝外胆管癌的胆管癌异质性和特定祖细胞生态位。
J Hematol Oncol. 2025 Jun 23;18(1):66. doi: 10.1186/s13045-025-01716-z.
5
Biliary microbiome profiling via 16 S rRNA amplicon sequencing in patients with cholangiocarcinoma, pancreatic carcinoma and choledocholithiasis.通过16S rRNA扩增子测序对胆管癌、胰腺癌和胆总管结石患者进行胆汁微生物群分析。
Sci Rep. 2025 May 15;15(1):16966. doi: 10.1038/s41598-025-00976-6.
6
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons.胆管癌的诊断:新的生物学与技术前沿
Diagnostics (Basel). 2025 Apr 16;15(8):1011. doi: 10.3390/diagnostics15081011.
7
Review of the mechanisms of the biliary-enteric axis in the development of cholangiocarcinoma.胆管癌发生发展中胆肠轴机制的综述
World J Clin Oncol. 2025 Apr 24;16(4):102374. doi: 10.5306/wjco.v16.i4.102374.
8
Bile-Liver phenotype: Exploring the microbiota landscape in bile and intratumor of cholangiocarcinoma.胆汁-肝脏表型:探索胆管癌胆汁和肿瘤内的微生物群落景观
Comput Struct Biotechnol J. 2025 Mar 18;27:1173-1186. doi: 10.1016/j.csbj.2025.03.030. eCollection 2025.
9
Chronic hepatitis B virus infection imbalances short-chain fatty acids and amino acids in the liver and gut via microbiota modulation.慢性乙型肝炎病毒感染通过调节微生物群导致肝脏和肠道中的短链脂肪酸和氨基酸失衡。
Gut Pathog. 2025 Apr 5;17(1):18. doi: 10.1186/s13099-025-00695-3.
10
Dysbiosis of Bile Microbiota in Cholangiocarcinoma Patients: A Comparison with Benign Biliary Diseases.胆管癌患者胆汁微生物群失调:与良性胆道疾病的比较
Int J Mol Sci. 2025 Feb 13;26(4):1577. doi: 10.3390/ijms26041577.
印度结直肠癌患者肠道微生物群与黄酮类降解菌普拉蒂黄酮分解菌的关联。
mSystems. 2019 Nov 12;4(6):e00438-19. doi: 10.1128/mSystems.00438-19.
4
A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma.胆管结石或远端胆管癌患者胆道微生物群的初步研究。
Biomed Res Int. 2019 Sep 25;2019:1092563. doi: 10.1155/2019/1092563. eCollection 2019.
5
Dysbiosis signatures of the microbial profile in tissue from bladder cancer.膀胱癌组织中微生物特征的失调特征。
Cancer Med. 2019 Nov;8(16):6904-6914. doi: 10.1002/cam4.2419. Epub 2019 Sep 30.
6
Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma.肝内胆管癌的肠道微生物群特征、胆汁酸代谢和细胞因子。
Hepatology. 2020 Mar;71(3):893-906. doi: 10.1002/hep.30852. Epub 2019 Aug 19.
7
Introduction to the Analysis of Environmental Sequences: Metagenomics with MEGAN.环境序列分析导论:使用MEGAN进行宏基因组学分析
Methods Mol Biol. 2019;1910:591-604. doi: 10.1007/978-1-4939-9074-0_19.
8
The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile.人类胆囊微生物组与生理状态和胆汁代谢特征有关。
Microbiome. 2019 Jul 4;7(1):100. doi: 10.1186/s40168-019-0712-8.
9
Cholangiocarcinoma: Epidemiology and risk factors.胆管癌:流行病学和危险因素。
Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24.
10
Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.分析中国男性膀胱癌患者的尿微生物组。
Front Cell Infect Microbiol. 2018 May 31;8:167. doi: 10.3389/fcimb.2018.00167. eCollection 2018.